PORTFOLIO MADE WITH CARE FDF Generics Chlorhexidine API
MADE WITH CARE Generics API LONG-TERM WORLDWIDE EXPERIENCE FDF HPAPI Intermediates API
SEAMLESS DEVELOPMENT FDF FIRST TO MARKET
GENERICS FDF MOLECULE PHARMACEUTICAL FORM & STRENGTH REFERENCE PRODUCT INDICATION DOSSIER STATUS Film-coated Apixaban tablets 2.5 mg, 5 mg Eliquis BMS/Pfizer Antithrombotic Filed: ANDA * Under preparation: EU Tablets Captopril 12.5 mg, 25 mg, 50 mg, 100 mg Captopril Mylan Hypertension Filed: ANDA * Daptomycin [2] Powder for solution for injection or infusion in glass vial 350 mg, 500 mg Cubicin Merck Antibiotic Approved: EU Filed: AU, KR, ZA Under preparation: CA Linezolid [2] Solution for infusion in plastic bag 2 mg/ml (300 ml) Zyvoxid Pfizer Antibiotic Approved: EU, CA Filed: ZA, JO Powder Meropenem for solution for injection in glass vial 500 mg, 1 g Meronem AstraZeneca Antibiotic Approved: EU, VN Filed: ZA Paracetamol Solution for infusion in glass vial 10 mg/ml (100 ml) Perfalgan BMS Analgesic Approved: EU, AU, CL, KH, PY, IR Filed: CA, MA, RU Prucalopride Succinate Film-coated tablets 1 mg, 2 mg Resolor Shire Chronic constipation Filed: EU Rasagiline Tartrate [1] Tablets 1 mg Azilect Teva Parkinson s disease Approved: EU Vertically integrated [API / FDF] FDA inspected site US DMF * Exclusivity deal for US market
AVAILABLE DOSSIERS MOLECULE PHARMACEUTICAL FORM & STRENGTH REFERENCE PRODUCT INDICATION DOSSIER STATUS Film-coated Rivaroxaban tablets 2.5 mg, 10 mg, 15 mg, 20 mg Xarelto Bayer Antithrombotic Filed: EU Sodium Oxybate Oral Solution in bottle 300 mg/ml Xyrem UCB Pharma Narcolepsy Approved: EU Film-coated [1] [3] Solifenacin tablets 5 mg, 10 mg Vesicare Astellas Pharma Overactive bladder Approved: EU Sugammadex Sodium [3] Solution for injection 200 mg/2 ml 500 mg/5 ml Bridion MSD Reversal of neuromuscular blockade in anesthesia Filed: EU Filed Q4 18: ANDA * Capsules Sunitinib Malate 12.5 mg, 25 mg, 37.5 mg, 50 mg Sutent Pfizer Renal carcinoma, pancreatic and stromal tumors Approved: EU Filed: JO Nebulizer Tobramycin solution in plastic ampoule blow-fill-seal 300 mg/5 ml Tobi Novartis Cystic fibrosis Approved: AU, EU, BR Filed Q4 18: ANDA * Thalidomide Capsules 50 mg Thalidomid Celgene Celgene Multiple myeloma Filed: EU [3] Vertically integrated [API / FDF] FDA inspected site US DMF US DMF forseen * Exclusivity deal for US market
GENERICS API MALTA Ambrisentan * Micafungin Sodium Solifenacin Succinate Apixaban Quetiapine Fumarate Sugammadex Sodium Cinacalcet HCl Rasagiline Mesylate Sunitinib Malate Dabigatran Etexilate Mesylate Rasagiline Tartrate Vildagliptin Desvenlafaxine Succinate Rivaroxaban Voriconazole Lorcaserin HCl Saxagliptin HCl * Zaleplon Vertically integrated [API / FDF] * Exclusivity deal for US market
AVAILABLE PORTFOLIO SPAIN Adapalene Fluvoxamine Maleate Mexiletine HCl Alendronate Sodium Gabapentin Mirtazapine Amoxapine Glimepiride Nepafenac [sterile and non sterile] Asenapine Maleate * Guanabenz Acetate Olopatadine HCl Brimonidine Tartrate Guanfacine HCl Paroxetine HCl Captopril Lamotrigine Pimecrolimus Clozapine Levobunol HCI Quetiapine Fumarate Cyclobenzaprine HCl Lorcaserin HCl Risperidone Desvenlafaxine Base Loxapine Base Tamsulosin HCl Enalapril Maleate Loxapine Succinate Venlafaxine HCl Etidronate Disodium Methisoprinol [Inosine Pranobex] Voriconazole Felodipine Metoprolol Succinate Vertically integrated [API / FDF] USP reference standard * Exclusivity deal for US market
MADE WITH CARE Chlorhexidine Pharma API FDF Biocide
CHLORHEXIDINE API AVAILABLE Chlorhexidine Base Chlorhexidine Digluconate 20% Solution Chlorhexidine Diacetate Chlorhexidine Dihydrochloride CHLORHEXIDINE DIGLUCONATE FDF - PHARMACEUTICAL GRADE UNDER DEVELOPMENT DOSSIERS STRENGTH CUTANEOUS SOLUTION INDICATION GALENIC FORM FORMATS AVAILABLE 2% 0.50% Alcoholic 70% transparent Alcoholic 70% coloured Alcoholic 70% transparent Alcoholic 70% coloured Disinfection of the skin prior to invasive medical procedures Disinfection of the intact skin prior to invasive medical procedures Hygienic and pre-operative hand disinfection Plastic bottles 30 ml, 100 ml, 250 ml More formats available on request
CHLORHEXIDINE DIGLUCONATE FDF - BIOCIDE GRADE AVAILABLE DOSSIERS STRENGTH CUTANEOUS SOLUTION GALENIC FORM INDICATION FORMATS AVAILABLE 2% Aqueous Blow-fill-seal ampoules and plastic bottles Antiseptic Alcoholic 70% transparent Alcoholic 70% coloured Plastic bottles Antiseptic Preoperative disinfection of the intact skin Single Dose (10 ml), 60 ml, 75 ml, 100 ml, 125 ml, 250 ml, 500 ml Aqueous Blow-fill-seal ampoules and plastic bottles 0.50% Alcoholic 70% transparent Alcoholic 70% coloured Plastic bottles Antiseptic More formats available on request UNDER DEVELOPMENT DOSSIERS GALENIC FORM STRENGTH GALENIC FORM INDICATION WIPES 2% SCRUB 4% Aqueous Alcoholic Transparent Coloured Antiseptic Preoperative disinfection of the intact skin Preoperative skin preparation Surgical hand scrub Healthcare personnel hand wash General skin and wound cleanser
MEDICHEM S.A. Carrer de Fructuós Gelabert, 6 08970 Sant Joan Despí, Barcelona - SPAIN Tel: +34 93 477 64 40 MEDICHEM USA, LLC Hoboken Business Center 50 Harrison Street, Suite 217 Hoboken, NJ 07030 - USA Tel: +1 201 420 1800 MEDICHEM, NRC Nanjing, PRC Tel: +86-18602518443 MEDICHEM MANUFACTURING (MALTA) LTD. Hal Far (BBG) MALTA MEDICHEM, S.A. - MANUFACTURING Celrà (Girona) SPAIN COMBINO PHARM (MALTA) LTD. Hal Far (BBG) MALTA October 2018 www.medichem.es info@medichem.es Products protected by valid patents are neither manufactured, nor offered for sale nor marketed in jurisdictions where such activities would constitute patent infringement. This brochure is informative only and it does not constitute any offer for sale, or be construed as representing an offer for sale. The current list only reflects the products and/or technologies that are available, under development or under consideration at Medichem, S.A., Medichem Manufacturing (Malta) Ltd. or Combino Pharm (Malta) Ltd., as applicable. Some products may be developed or produced for internal and/or experimental uses/purposes with no commercial aim. For any query or commercial request, please, refer to your contacts at Medichem, S.A., Medichem Manufacturing (Malta) Ltd. or Combino Pharm (Malta) Ltd., as applicable.